RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,029 | +22.0% | 20,343 | 0.0% | 0.00% | – |
| Q2 2023 | $50,044 | -11.6% | 20,343 | -18.7% | 0.00% | – |
| Q1 2023 | $56,584 | -36.1% | 25,037 | 0.0% | 0.00% | – |
| Q4 2022 | $88,570 | -92.0% | 25,037 | -17.7% | 0.00% | -100.0% |
| Q3 2022 | $1,110,043 | +88.1% | 30,430 | -0.9% | 0.00% | – |
| Q2 2022 | $590,035 | +55.6% | 30,705 | +116.1% | 0.00% | – |
| Q1 2022 | $379,272 | +72.4% | 14,206 | +69.0% | 0.00% | – |
| Q3 2021 | $220,000 | -22.0% | 8,407 | -4.7% | 0.00% | – |
| Q2 2021 | $282,000 | -3.4% | 8,820 | +6.2% | 0.00% | – |
| Q1 2021 | $292,000 | +3.5% | 8,307 | -5.4% | 0.00% | – |
| Q4 2020 | $282,000 | -7.8% | 8,780 | +8.1% | 0.00% | – |
| Q3 2020 | $306,000 | -12.6% | 8,122 | 0.0% | 0.00% | – |
| Q2 2020 | $350,000 | – | 8,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |